|
Volumn 20, Issue SUPPL. 1, 2002, Pages 43-53
|
Applications of economic models in healthcare: The introduction of pioglitazone in Sweden
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
INSULIN;
METFORMIN;
PIOGLITAZONE;
ROSIGLITAZONE;
SULFONYLUREA DERIVATIVE;
UNCLASSIFIED DRUG;
BIOSTATISTICS;
CLINICAL PRACTICE;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
ECONOMIC ASPECT;
ECONOMIC EVALUATION;
HEALTH CARE SYSTEM;
HEALTH ECONOMICS;
INCIDENCE;
INSULIN RESISTANCE;
MAXIMUM TOLERATED DOSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
QUALITY ADJUSTED LIFE YEAR;
QUALITY OF LIFE;
REIMBURSEMENT;
REVIEW;
STATISTICAL ANALYSIS;
STATISTICAL MODEL;
SWEDEN;
|
EID: 0036261467
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-200220001-00005 Document Type: Review |
Times cited : (27)
|
References (33)
|